Skip to main content
Article thumbnail
Location of Repository

Potential antiproteolytic effects of L-leucine: observations of in vitro and in vivo studies

By Nelo E Zanchi, Humberto Nicastro and Antonio H Lancha

Abstract

The purpose of present review is to describe the effect of leucine supplementation on skeletal muscle proteolysis suppression in both in vivo and in vitro studies. Most studies, using in vitro methodology, incubated skeletal muscles with leucine with different doses and the results suggests that there is a dose-dependent effect. The same responses can be observed in in vivo studies. Importantly, the leucine effects on skeletal muscle protein synthesis are not always connected to the inhibition of skeletal muscle proteolysis. As a matter of fact, high doses of leucine incubation can promote suppression of muscle proteolysis without additional effects on protein synthesis, and low leucine doses improve skeletal muscle protein ynthesis but have no effect on skeletal muscle proteolysis. These research findings may have an important clinical relevancy, because muscle loss in atrophic states would be reversed by specific leucine supplementation doses. Additionally, it has been clearly demonstrated that leucine administration suppresses skeletal muscle proteolysis in various catabolic states. Thus, if protein metabolism changes during different atrophic conditions, it is not surprising that the leucine dose-effect relationship must also change, according to atrophy or pathological state and catabolism magnitude. In conclusion, leucine has a potential role on attenuate skeletal muscle proteolysis. Future studies will help to sharpen the leucine efficacy on skeletal muscle protein degradation during several atrophic states

Topics: Review
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2488337
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2003). amino acid-dependent regulation of autophagy in C2C12 myotubes.
    2. (2005). Attaix D: A leucine-supplemented diet restores the defective postprandial inhibition of proteasome-dependent proteolysis in aged rat skeletal muscle.
    3. (2003). Attaix D: Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.
    4. (1984). Clark AS: Specificity of the effects of leucine and its metabolites on protein degradation in skeletal muscle.
    5. (1996). DeFronzo RA: Differential responsiveness of protein synthesis and degradation to amino acid availability in humans. Diabetes
    6. (1987). DeFronzo RA: Effect of insulin and plasma amino acid concentrations on leucine metabolism in man role of substrate availability on estimates of whole body protein synthesis.
    7. (1999). Differences in estimates of forearm protein synthesis between leucine and phenylalanine tracers following unbalanced amino acid infusion. Metabolism
    8. (1982). Does leucine, leucyltRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?
    9. (2008). Effect of prolonged intravenous glucose and essential amino acid infusion on nitrogen balance, muscle protein degradation and ubiquitinconjugating enzyme gene expression in calves. Nutr Metab (Lond)
    10. (1978). Effect of starvation on the turnover and metabolic response to leucine.
    11. (1987). EJ: Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man.
    12. (2006). Ferrando AA: Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress.
    13. (2004). Gomes-Marcondes MC: Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet. Endocr Relat Cancer
    14. (1969). Goodman HM: Effects of disuse and denervation on amino acid transport by skeletal muscle.
    15. (1987). Iori E, Tiengo A, Crepaldi G: Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo.
    16. (1974). Ip MM: Measurement of protein turnover in rat liver with (14C)carbonate. Protein turnover during liver regeneration.
    17. (1980). JB: A rapid, sensitive method for the determination of 3-methylhistidine levels in urine and plasma using high pressure liquid chromatography. Anal Biochem
    18. (1988). JE: Methods for studying protein synthesis and degradation in liver and skeletal muscle.
    19. (1984). Layman DK: Effects of leucine on in vitro protein synthesis and degradation in rat skeletal muscles.
    20. (1992). Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans.
    21. (2000). Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway.
    22. (2005). Leucine suppresses myofibrillar proteolysis by down-regulating ubiquitin-proteasome pathway in chick skeletal muscles.
    23. (1994). Leucine-specific binding of photoreactive Leu7-MAP to a high molecular weight protein on the plasma membrane of the isolated rat hepatocyte.
    24. (2000). López-Soriano FJ, Argilés JM: Branched-chain amino acids inhibit proteolysis in rat skeletal muscle: mechanisms involved.
    25. (2006). Mawatari K: Nutraceutical effects of branched-chain amino acids in skeletal muscle.
    26. (1991). Miotto G: Amino acid control of proteolysis in perfused livers of synchronously fed rats. Mechanism and specificity of alanine co-regulation.
    27. (2001). MJ: Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids.
    28. (2008). Modulations of muscle protein metabolism by branched-chainNutrition & Metabolism
    29. (1982). Mortimore GE: Multifunctional control of amino acids of deprivation-induced proteolysis in liver. Role of leucine.
    30. (2006). Nair KS: Assessment of branched-chain amino Acid status and potential for biomarkers.
    31. (2002). Nishizawa N: Rapid suppression of protein degradation in skeletal muscle after oral feeding of leucine in rats.
    32. (1997). OA: Effects of leucine on whole body leucine, valine, and threonine metabolism in humans.
    33. (2005). Observations of branched-chain amino acid administration in humans.
    34. (1995). Overnight branched-chain amino acid infusion causes sustained suppression of muscle proteolysis. Metabolism
    35. (1997). Protein synthesis and degradation change rapidly in response to food intake in muscle of food-deprived mice.
    36. (1983). Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem J
    37. (2001). Rabuazzo AM: Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP-to-ADP ratio.
    38. (1975). Reid SS: Leucine: a possible regulator of protein turnover in muscle.
    39. (2003). Rennie MJ: Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study.
    40. (2006). RR: A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly.
    41. (2005). RR: Method for the determination of the arteriovenous muscle protein balance during non-steady-state blood and muscle amino acid concentrations.
    42. (1966). RR: Myosin and total protein turnover in denervated rat skeletal muscle.
    43. (1997). Simultaneous measurements of free amino acid patterns of plasma, muscle and erythrocytes in healthy human subjects. Clin Nutr
    44. (2000). Stimulation of in vitro rat muscle protein synthesis by leucine decreases with age.
    45. (1977). Studies concerning the specificity of the effect of leucine on the turnover of proteins in muscles of control and diabetic rats. Biochim Biophys Acta
    46. (2004). Tawa NE: Leucine inhibits proteolysis by the mTOR kinase signaling pathway in skeletal muscle.
    47. (2007). Tisdale MJ: Effect of branched-chain amino acids on muscle atrophy in cancer cachexia.
    48. (1984). Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation. Metabolism
    49. (1995). Wolfe RR: Oral branched-chain amino acids decrease whole-body proteolysis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.